Neuropathological alterations in Alzheimer disease

Serrano-Pozo, A., Frosch, M. P., Masliah, E., Hyman, B. T.·2011·Cold Spring Harbor Perspectives in Medicine
DOI 10.1101/cshperspect.a006189

Cited by (1,028)

Items 401–500 of 1,028

  1. The role of neuroinflammation and amyloid in cognitive impairment in an APP / PS 1 transgenic mouse model of Alzheimer's disease
    Shenghua Zhu, Junhui Wang, Yanbo Zhang, Jue He, Jiming Kong, Junfeng Wang, Xin‐Min Li · 2017 · CNS Neuroscience & Therapeutics
  2. Mitochondria-Targeted Protective Compounds in Parkinson’s and Alzheimer’s Diseases
    Carlos Fernández‐Moriano, Elena González‐Burgos, María Pilar Gómez-Serranillos · 2015 · Oxidative Medicine and Cellular Longevity
  3. Protective effects of Anthocyanins against Amyloid beta-induced neurotoxicity in vivo and in vitro
    Haroon Badshah, Tae Hyun Kim, Myeong Ok Kim · 2014 · Neurochemistry International
  4. Liposomes functionalized to overcome the blood–brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model
    Francesca Re, Salvati, Sesana, Cambianica, Giulio Sancini, Masserini, Gregori · 2013 · International Journal of Nanomedicine
  5. Blood will out: vascular contributions to Alzheimer’s disease
    Sidney Strickland · 2018 · Journal of Clinical Investigation
  6. Liraglutide Protects Against Brain Amyloid-β1–42 Accumulation in Female Mice with Early Alzheimer’s Disease-Like Pathology by Partially Rescuing Oxidative/Nitrosative Stress and Inflammation
    Ana Isabel Duarte, Emanuel Candeias, Inês Nuno Alves, Débora Mena, Daniela Franco da Silva, Nuno J. Machado, Elisa Julião Campos, Maria S. Santos, Catarina Resende Oliveira, Paula Isabel Moreira · 2020 · International Journal of Molecular Sciences
  7. New fluid biomarkers tracking non-amyloid-β and non-tau pathology in Alzheimer’s disease
    Sun Ah Park, Song Mi Han, Chae Eun Kim · 2020 · Experimental & Molecular Medicine
  8. DYRK1A: a down syndrome-related dual protein kinase with a versatile role in tumorigenesis
    A. Laham, M. Saber-Ayad, R. El-Awady · 2020 · Cellular and Molecular Life Sciences
  9. Improved Alzheimer’s Disease Detection by MRI Using Multimodal Machine Learning Algorithms
    Gopi Battineni, Mohammad Amran Hossain, Nalini Chintalapudi, Enea Traini, Venkata Rao Dhulipalla, Ramasamy Mariappan, Francesco Amenta · 2021 · Diagnostics
  10. Important roles of linoleic acid and α-linolenic acid in regulating cognitive impairment and neuropsychiatric issues in metabolic-related dementia
    Oh. Yoen Kim, Juhyun Song · 2023 · Life Sciences
  11. Anti-amyloid Aggregation Activity of Natural Compounds: Implications for Alzheimer’s Drug Discovery
    Xian‐Le Bu, Praveen P. N. Rao, Yan‐Jiang Wang · 2015 · Molecular Neurobiology
  12. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR)
    Ferreira, João P.S., Albuquerque, Hélio M.T., Cardoso, Susana M., Silva, Artur M.S., Silva, Vera L.M. · 2021 · European Journal of Medicinal Chemistry
  13. Mangiferin: A multipotent natural product preventing neurodegeneration in Alzheimer’s and Parkinson’s disease models
    Feng, Si-Tong, Wang, Zhen-Zhen, Yuan, Yu-He, Sun, Hong-Mei, Chen, Nai-Hong, Zhang, Yi · 2019 · Pharmacological Research
  14. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers
    Ugalde, Cathryn L., Finkelstein, David I., Lawson, Victoria A., Hill, Andrew F. · 2016 · Journal of Neurochemistry
  15. The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease
    Hlin Kvartsberg, Tammaryn Lashley, Christina E. Murray, Gunnar Brinkmalm, Nicholas C. Cullen, Kina Höglund, Henrik Zetterberg, Kaj Blennow, Erik Portelius · 2018 · Acta Neuropathologica
  16. Neural substrates of cognitive reserve in Alzheimer's disease spectrum and normal aging
    Dong Hyuk Lee, Peter Lee, Sang Won Seo, Jee Hoon Roh, Minyoung Oh, Jungsu S. Oh, Seung Jun Oh, Jae Seung Kim, Yong Jeong · 2018 · NeuroImage
  17. The role of SLC transporters for brain health and disease
    Yen Thi-Kim Nguyen, Hoa Thi Thuy Ha, Tra H. Nguyen, Long Nam Nguyen · 2021 · Cellular and Molecular Life Sciences
  18. Single-cell RNA-sequencing identifies disease-associated oligodendrocytes in male APP NL-G-F and 5XFAD mice
    Park, Hanseul, Cho, Byounggook, Kim, Hongwon, Saito, Takashi, Saido, Takaomi C., Won, Kyoung-Jae, Kim, Jongpil · 2023 · Nature Communications
  19. Bioenergetic Mechanisms in Astrocytes May Contribute to Amyloid Plaque Deposition and Toxicity
    Wen Fu, Diya Shi, David A. Westaway, Jack H. Jhamandas · 2015 · Journal of Biological Chemistry
  20. Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: From structural insights to post-transcriptional regulatory roles
    Uriya Bekenstein, Hermona Soreq · 2012 · Molecular and Cellular Neuroscience
  21. Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model
    Litvinchuk, Alexandra, Huynh, Tien‐Phat V., Shi, Yang, Jackson, Rosemary J., Finn, Mary B., Manis, Melissa, Francis, Caroline M., Tran, Ainsley C., Sullivan, Patrick M., Ulrich, Jason D. et al. · 2021 · Annals of Neurology
  22. Amyloid-β impairs mitochondrial dynamics and autophagy in Alzheimer’s disease experimental models
    Macarena de la Cueva, Desireé Antequera, Lara Ordóñez‐Gutiérrez, Francisco G. Wandosell, Antoni Camins, Eva Carro, Fernando Benito Bartolomé · 2022 · Scientific Reports
  23. SUMO and Alzheimer’s Disease
    Linda Lee, Mikako Sakurai, Shinsuke Matsuzaki, Ottavio Arancio, Paul E. Fraser · 2013 · NeuroMolecular Medicine
  24. Early Changes in Hippocampal Neurogenesis in Transgenic Mouse Models for Alzheimer’s Disease
    Michael Stefan Unger, Julia Marschallinger, Julia Kaindl, Corinna Höfling, Steffen Roßner, Michael Thomas Heneka, Annemie Van der Linden, Ludwig Aigner · 2016 · Molecular Neurobiology
  25. Current status of non-viral gene therapy for CNS disorders
    Rahul Dev Jayant, Daniela Sosa, Ajeet Kumar Kaushik, Venkata Subba Rao Atluri, Arti Vashist, Asahi Tomitaka, Madhavan Nair · 2016 · Expert Opinion on Drug Delivery
  26. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis
    Sakakibara, Yasufumi, Sekiya, Michiko, Saito, Takashi, Saido, Takaomi C., Iijima, Koichi M. · 2018 · BMC Neuroscience
  27. Blood–Brain Barrier and Neurodegenerative Diseases—Modeling with iPSC-Derived Brain Cells
    Ying‐Chieh Wu, Tuuli-Maria Sonninen, Sanni Peltonen, Jari Koıstınaho, Šárka Lehtonen · 2021 · International Journal of Molecular Sciences
  28. Neuropathological approaches to cerebral aging and neuroplasticity
    K. A. Jellinger, Johannes Attems · 2013 · Dialogues in Clinical Neuroscience
  29. Ubiquitin C-terminal hydrolase-L1 (UCH-L1) as a therapeutic and diagnostic target in neurodegeneration, neurotrauma and neuro-injuries
    Kevin K. W. Wang, Zhi-Hui Yang, G. Sarkis, Isabel Torres, V. Raghavan · 2017 · Expert opinion on therapeutic targets
  30. New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease
    Laura A. Best, Christine Ghadery, Nicola Pavese, Yen Tai, Antonio P. Strafella · 2019 · Current Neurology and Neuroscience Reports
  31. Phospholipase C families: Common themes and versatility in physiology and pathology
    Katan, Matilda, Cockcroft, Shamshad · 2020 · Progress in Lipid Research
  32. Three-dimensional analysis of synaptic organization in the hippocampal CA1 field in Alzheimer’s disease
    Marta Montero‐Crespo, Marta Domínguez-Álvaro, Lidia Alonso‐Nanclares, Javier DeFelipe, Lidia Blázquez‐Llorca · 2020 · Brain
  33. Overexpression of Hsp27 ameliorates symptoms of Alzheimer's disease in APP/PS1 mice
    Melinda Erzsébet Tóth, Viktor Szegedi, Edina Varga, Gábor Juhász, János Horváth, Emőke Borbély, Balázs Csibrány, Róbert Alföldi, Nikolett Lénárt, Botond Penke et al. · 2013 · Cell Stress and Chaperones
  34. Amyloid Deposition Is Linked to Aberrant Entorhinal Activity among Cognitively Normal Older Adults
    Willem Huijbers, Elizabeth C. Mormino, Sarah E. Wigman, Andrew M. Ward, Patrizia Vannini, Donald G. McLaren, John Alex Becker, Aaron P. Schultz, Trey Hedden, Keith A. Johnson et al. · 2014 · Journal of Neuroscience
  35. Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer’s Disease: an Emerging Issue in Geriatric NeuroHIV
    Benedetta Milanini, Victor Valcour · 2017 · Current HIV/AIDS Reports
  36. Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer’s Disease?
    Sávio Monteiro dos Santos, Camila Fernanda Rodrigues Romeiro, Caroline Azulay Rodrigues, Alícia Renata Lima Cerqueira, Marta Chagas Monteiro · 2019 · Oxidative Medicine and Cellular Longevity
  37. Neurovascular unit dysregulation, white matter disease, and executive dysfunction: the shared triad of vascular cognitive impairment and Alzheimer disease
    Alexander Levit, Vladimir Hachinski, Shawn Narain Whitehead · 2020 · GeroScience
  38. Inhibitory Parvalbumin Basket Cell Activity is Selectively Reduced during Hippocampal Sharp Wave Ripples in a Mouse Model of Familial Alzheimer's Disease
    Adam Caccavano, P. Lorenzo Bozzelli, Patrick Alexander Forcelli, Daniel T.S. Pak, Jian‐Young Wu, Katherine E. Conant, Stefano Vicini · 2020 · Journal of Neuroscience
  39. Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review
    Ying Zhang, Pan Guo, Zhe Ma, Peng Lü, Dereje Kebebe, Zhidong Liu · 2021 · Journal of Nanobiotechnology
  40. Alzheimer’s disease – the journey of a healthy brain into organ failure
    Todd Eliot Golde · 2022 · Molecular Neurodegeneration
  41. Capsaicin, The Vanilloid Receptor TRPV1 Agonist in Neuroprotection: Mechanisms Involved and Significance
    O. Abdel-Salam, G. Mózsik · 2023 · Neurochemical Research
  42. Exploring the role of COX-2 in Alzheimer's disease: Potential therapeutic implications of COX-2 inhibitors
    Nathalie Moussa, Ninar Dayoub · 2023 · Saudi Pharmaceutical Journal
  43. Modulation of Hippocampal Circuits by Muscarinic and Nicotinic Receptors
    Holger Dannenberg, Kimberly Young, Michael Erik Hasselmo · 2017 · Frontiers in Neural Circuits
  44. Mitochondrial therapeutic interventions in Alzheimer’s disease
    Vo Van Giau, Seong Soo A. An, John Hulme · 2018 · Journal of the Neurological Sciences
  45. Neuroprotective effect of quercetin nanoparticles: A possible prophylactic and therapeutic role in alzheimer's disease.
    R. Rifaai, S. Mokhemer, E. Saber, S. Abd El-Aleem, N. El-Tahawy · 2020 · Journal of Chemical Neuroanatomy
  46. Molecular chaperones and protein folding as therapeutic targets in Parkinson’s disease and other synucleinopathies
    Darius Ebrahimi‐Fakhari, Laiq-Jan Saidi, Lara Wahlster · 2013 · Acta Neuropathologica Communications
  47. Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology
    Christoph N. Köhler · 2016 · Acta Neuropathologica
  48. Non-Fibrillar Oligomeric Amyloid-β within Synapses
    Eleanor K. Pickett, Robert M. Koffie, Susanne Wegmann, Christopher M. Henstridge, Abigail G. Herrmann, Martí Colom‐Cadena, Alberto Lleó, Kevin R. Kay, Melissa Vaught, Roy Jason Soberman et al. · 2016 · Journal of Alzheimer s Disease
  49. Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions
    Ren, Fang, Wei, Jing, Chen, Qingxin, Hu, Mengling, Yu, Lu, Mi, Jianing, Zhou, Xiaogang, Qin, Dalian, Wu, Jianming, Wu, Anguo · 2025 · Acta Pharmaceutica Sinica B
  50. The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases
    Rozpędek-Kamińska, Wioletta, Siwecka, Natalia, Wawrzynkiewicz, Adam, Wojtczak, Radosław, Pytel, Dariusz, Diehl, J. Alan, Majsterek, Ireneusz · 2020 · International Journal of Molecular Sciences
  51. Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer’s disease
    Chirag Patel, John J. Georrge, Krunal Modi, Moksha B. Narechania, Daxesh P. Patel, Frank J. Gonzalez, Himanshu Pandya · 2017 · Journal of Biomolecular Structure and Dynamics
  52. On the Role of Store-Operated Calcium Entry in Acute and Chronic Neurodegenerative Diseases
    Agnese Secondo, Giacinto Bagetta, Diana Amantea · 2018 · Frontiers in Molecular Neuroscience
  53. Induction of Accelerated Aging in a Mouse Model
    Nanshuo Cai, Yifan Wu, Yan Y. Huang · 2022 · Cells
  54. Impaired expression of GABA transporters in the human Alzheimer’s disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus
    Tessa E. Fuhrer, Thulani Hansika Palpagama, Henry John Waldvogel, Beth J. L. Synek, Clinton P. Turner, Richard L. M. Faull, Andrea Kwakowsky · 2017 · Neuroscience
  55. Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5
    A. Harrison Brody, Stephen M. Strittmatter · 2017 · Advances in pharmacology
  56. Roles of vascular risk factors in the pathogenesis of dementia
    Shuko Takeda, H. Rakugi, R. Morishita · 2019 · Hypertension Research
  57. Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-Amyloid plaques in an early-onset Alzheimer’s disease mouse model
    Christian Griñán‐Ferré, Laura Marsal-García, Aina Bellver‐Sanchís, Shukkoor Muhammed Kondengaden, Ravi Chakra Turaga, Santiago Vázquez, Mercè Pallàs · 2019 · Aging
  58. Critical Appraisal of Amyloid Lowering Agents in AD
    Boris Decourt, Fadel Boumelhem, Evans D. Pope, Jiong Shi, Zoltan K. Mari, Marwan Noel Sabbagh · 2021 · Current Neurology and Neuroscience Reports
  59. Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations
    Yuto Uchida, Hirohito Kan, Keita Sakurai, Kenichi Oishi, Noriyuki Matsukawa · 2022 · Frontiers in Neuroscience
  60. Aβ plaques
    Lary C. Walker · 2020 · Free Neuropathology
  61. Epigenetic Changes in Alzheimer’s Disease: DNA Methylation and Histone Modification
    Laura Maria De Plano, Alessandra Saitta, Salvatore Oddo, Antonella Caccamo · 2024 · Cells
  62. Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease
    Vincent C. Lombardi, Kenny L. De Meirleir, Krishnamurthy Subramanian, Sam M. Nourani, Ruben Karim Dagda, Shannon L. Delaney, András Palotás · 2018 · The Journal of Nutritional Biochemistry
  63. Recent Progress in Alzheimer’s Disease Research, Part 1: Pathology
    Francis T. Hane, Brenda Yasie Lee, Zoya Leonenko · 2017 · Journal of Alzheimer s Disease
  64. Neuropathological assessment of the Alzheimer spectrum
    K. A. Jellinger · 2020 · Journal of Neural Transmission
  65. Alzheimer’s disease as a viral disease: Revisiting the infectious hypothesis
    Francesco Bruno, Paolo Abondio, Rossella Bruno, Leognano Ceraudo, Ersilia Paparazzo, Luigi Citrigno, Donata Luiselli, Amalia Cecilia Bruni, Giuseppe Passarino, Rosanna Colao et al. · 2023 · Ageing Research Reviews
  66. Identification of neurotoxic cytokines by profiling Alzheimer’s disease tissues and neuron culture viability screening
    Levi Benjamin Wood, Ashley R. Winslow, Elizabeth A. Proctor, Declan McGuone, Daniel A. Mordes, Matthew P. Frosch, Bradley T. Hyman, Douglas A. Lauffenburger, Kevin M. Haigis · 2015 · Scientific Reports
  67. Potential Neuroprotective Effects of Adiponectin in Alzheimer’s Disease
    Roy Chun-Laam Ng, Koon‐Ho Chan · 2017 · International Journal of Molecular Sciences
  68. Digital ELISA for the quantification of attomolar concentrations of Alzheimer's disease biomarker protein Tau in biological samples
    Elena Ruiz, Deborah Decrop, Karen Ven, Lisa Tripodi, Karen Leirs, Joëlle Rosseels, Marlies Van de Wouwer, Nick Geukens, Ann De Vos, Eugeen Vanmechelen et al. · 2018 · Analytica Chimica Acta
  69. Current trends in blood biomarker detection and imaging for Alzheimer’s disease
    Hu, Shun, Yang, Changwen, Luo, Haiming · 2022 · Biosensors and Bioelectronics
  70. Multi-Target Drug Candidates for Multifactorial Alzheimer’s Disease: AChE and NMDAR as Molecular Targets
    Uddin, Md. Sahab, Al Mamun, Abdullah, Kabir, Md. Tanvir, Ashraf, Ghulam Md, Bin-Jumah, May N., Abdel-Daim, Mohamed M. · 2021 · Molecular Neurobiology
  71. Exercise for the diabetic brain: how physical training may help prevent dementia and Alzheimer’s disease in T2DM patients
    Sebastian Bertram, Klara Brixius, Christian Karl Brinkmann · 2016 · Endocrine
  72. Tau Imaging in Neurodegenerative Diseases Using Positron Emission Tomography
    Yi Ting Wang, Paul Edison · 2019 · Current Neurology and Neuroscience Reports
  73. P301L tau expression affects glutamate release and clearance in the hippocampal trisynaptic pathway
    Holly C. Hunsberger, Carolyn C. Rudy, Seth R. Batten, Greg A. Gerhardt, Miranda Nicole Reed · 2014 · Journal of Neurochemistry
  74. Alzheimer’s disease-associated mutations increase amyloid precursor protein resistance to γ-secretase cleavage and the Aβ42/Aβ40 ratio
    Ting-Hai Xu, Yan Yan, Yanyong Kang, Yi Jiang, Karsten Melcher, H. Eric Xu · 2016 · Cell Discovery
  75. Amyloid-β Increases Tau by Mediating Sirtuin 3 in Alzheimer’s Disease
    Junxiang Yin, Pengcheng Han, Melissa Song, Megan Nielsen, Thomas G. Beach, Geidy E. Serrano, Winnie S. Liang, Richard J. Caselli, Jiong Shi · 2018 · Molecular Neurobiology
  76. Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model
    Cook, Casey, Kang, Silvia S., Carlomagno, Yari, Lin, Wen-Lang, Yue, Mei, Kurti, Aishe, Shinohara, Mitsuru, Jansen-West, Karen, Perkerson, Emilie, Castanedes-Casey, Monica et al. · 2015 · Human Molecular Genetics
  77. Fructose consumption reduces hippocampal synaptic plasticity underlying cognitive performance
    Pedro Cisternas, Paulina Liberman Salazar, Felipe G. Serrano, Carla Montecinos-Oliva, Sebastián B. Arredondo, Lorena Varela‐Nallar, Salesa Barja Y., Carlos Pablo Vio, Fernando Gómez‐Pinilla, Nibaldo C. Inestrosa · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  78. Tau and MAPT genetics in tauopathies and synucleinopathies
    Etienne Léveillé, Owen A. Ross, Ziv Gan‐Or · 2021 · Parkinsonism & Related Disorders
  79. Bioactive Compounds and Their Derivatives: An Insight into Prospective Phytotherapeutic Approach against Alzheimer’s Disease
    Fahadul Islam, Jannatul Fardous Khadija, Md. Harun-Or-Rashid, Md. Saidur Rahaman, Mohamed H. Nafady, Md. Rezaul Islam, Aklima Akter, Talha Bin Emran, Polrat Wilairatana, Mohammad Suleiman Mubarak · 2022 · Oxidative Medicine and Cellular Longevity
  80. An Insight into Cellular and Molecular Mechanisms Underlying the Pathogenesis of Neurodegeneration in Alzheimer’s Disease
    Yashumati Ratan, Aishwarya Rajput, Sushmita Maleysm, Aaushi Pareek, Vivek Kumar Jain, Ashutosh Pareek, Ranjeet Kaur, Gurjit Singh · 2023 · Biomedicines
  81. The Use of Tau PET to Stage Alzheimer Disease According to the Braak Staging Framework
    Arthur C. Macedo, Cécile Tissot, Joseph Therriault, Stijn Servaes, Yi-Ting Wang, Jaime Fernández Arias, Nesrine Rahmouni, Firoza Zubeida Lussier, Marie R. Vermeiren, Gleb Bezgin et al. · 2023 · Journal of Nuclear Medicine
  82. Glial fibrillary acidic protein in Alzheimer’s disease: a narrative review
    Florine Leipp, Jérôme Vialaret, Pablo Mohaupt, Salomé Coppens, Aurore Jaffuel, Ann‐Christin Niehoff, Sylvain Lehmann, Christophe Hirtz · 2024 · Brain Communications
  83. Resting State fMRI Reveals Diminished Functional Connectivity in a Mouse Model of Amyloidosis
    Shah, Disha, Jonckers, Elisabeth, Praet, Jelle, Vanhoutte, Greetje, Delgado y Palacios, Rafael, Bigot, Christian, D’Souza, Dany V., Verhoye, Marleen, Van der Linden, Annemie · 2013 · PLoS ONE
  84. Resting-State Functional Connectivity Changes in Aging apoE4 and apoE-KO Mice
    Valerio Zerbi, Maximilian Wiesmann, Tim L. Emmerzaal, Diane Jansen, Maarten Van Beek, Martina P.C. Mutsaers, Christian F. Beckmann, Arend Heerschap, Amanda J. Kiliaan · 2014 · Journal of Neuroscience
  85. Gulf War Agent Exposure Causes Impairment of Long-Term Memory Formation and Neuropathological Changes in a Mouse Model of Gulf War Illness
    Zuchra Zakirova, Miles Tweed, Gogce C. Crynen, Jon M. Reed, Laila I. Abdullah, Nadee Nissanka, Myles A. Mullan, MICHAEL J. MULLAN, Venkatarajan Subramanian Mathura, Fiona Crawford et al. · 2015 · PLoS ONE
  86. The protective role of plant biophenols in mechanisms of Alzheimer's disease
    Syed Haris Omar, Christopher Scott, Adam S. Hamlin, Hassan K. Obied · 2017 · The Journal of Nutritional Biochemistry
  87. Amyloid β inhibits retinoic acid synthesis exacerbating A lzheimer disease pathology which can be attenuated by an retinoic acid receptor α agonist
    Maria Beatriz C.V. Goncalves, Earl E. Clarke, Carl Hobbs, Tony Malmqvist, Robert M. J. Deacon, Julian Jack, Jonathan P. T. Corcoran · 2013 · European Journal of Neuroscience
  88. The aging brain and anesthesia
    Emery N. Brown, Patrick L. Purdon · 2013 · Current Opinion in Anaesthesiology
  89. The pericyte–glia interface at the blood–brain barrier
    Giannoni, Patrizia, Badaut, Jerome, Dargazanli, Cyril, De Maudave, Alexis Fayd’Herbe, Klement, Wendy, Costalat, Vincent, Marchi, Nicola · 2018 · Clinical Science
  90. Use of Genetically Modified Mesenchymal Stem Cells to Treat Neurodegenerative Diseases
    Robert D. Wyse, Gary Leo Dunbar, Julien Rossignol · 2014 · International Journal of Molecular Sciences
  91. Development and validation of a salivary tau biomarker in Alzheimer's disease
    Heather Pekeles, Hamid Y. Qureshi, Hemant K. Paudel, Hyman M. Schipper, Mervyn Gornistky, Howard Mark Chertkow · 2018 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  92. An update on the interactions between Alzheimer's disease, autophagy and inflammation
    Mehmet Bostancıklıoğlu · 2019 · Gene
  93. Aβ oligomers trigger necroptosis-mediated neurodegeneration via microglia activation in Alzheimer’s disease
    Natalia Salvadores, Inés Moreno‐González, Nazaret Gamez, Gabriel Quiroz, Laura Vegas‐Gomez, Marcela Escandón, Sebastián Jiménez, Javier Vitórica, Antonia Gutiérrez, Claudio A. Soto et al. · 2022 · Acta Neuropathologica Communications
  94. Studying neurodegenerative diseases in culture models
    Johannes C. M. Schlachetzki, Soraya Wilke Saliba, Antônio Carlos Pinheiro de Oliveira · 2013 · Brazilian Journal of Psychiatry
  95. Olive Oil Phenols as Promising Multi-targeting Agents Against Alzheimer’s Disease
    Stefania Rigacci · 2015 · Advances in experimental medicine and biology
  96. Neuronal Pentraxin 2 predicts medial temporal atrophy and memory decline across the Alzheimer’s disease spectrum
    Swanson, Ashley, Willette, A.A. · 2016 · Brain, Behavior, and Immunity
  97. Amyloid and tau PET demonstrate region-specific associations in normal older people
    Samuel Neal Lockhart, Michael Schöll, Suzanne L. Baker, Nagehan Ayakta, Kaitlin N. Swinnerton, Rachel K. Bell, Taylor J. Mellinger, Vyoma D. Shah, James P. O’Neil, Mustafa Janabi et al. · 2017 · NeuroImage
  98. Three-dimensional analysis of synapses in the transentorhinal cortex of Alzheimer’s disease patients
    Domínguez-Álvaro, M., Montero-Crespo, M., Blazquez-Llorca, L., Insausti, R., DeFelipe, J., Alonso-Nanclares, L. · 2018 · Acta Neuropathologica Communications
  99. Multiple Layers of CDK5R1 Regulation in Alzheimer’s Disease Implicate Long Non-Coding RNAs
    Marco Spreafico, Barbara Grillo, Francesco Rusconi, Elena Battaglioli, Marco Venturin · 2018 · International Journal of Molecular Sciences
  100. Laser ablation ICP-MS for simultaneous quantitative imaging of iron and ferroportin in hippocampus of human brain tissues with Alzheimer's disease
    María Cruz‐Alonso, Beatriz Fernández, Ana Navarro, Susana Junceda, Aurora Astudillo, Rosario Pereiro · 2019 · Talanta